Prospects in folate receptor-targeted radionuclide therapy
Targeted radionuclide therapy is based on systemic application of particle-emitting radiopharmaceuticals which are directed towards a specific tumor-associated target. Accumulation of the radiopharmaceutical in targeted cancer cells results in high doses of absorbed radiation energy whereas toxicity...
Main Authors: | Cristina eMüller, Roger eSchibli |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00249/full |
Similar Items
-
Folate Receptor Targeted Alpha-Therapy Using Terbium-149
by: Cristina Müller, et al.
Published: (2014-03-01) -
FOLATE CONJUGATED DENDRIMERS FOR TARGETED ANTICANCER THERAPY
by: Andrews, Shannon
Published: (2014) -
Tissue distribution and tumor uptake of folate receptor–targeted epothilone folate conjugate, BMS-753493, in CD2F1 mice after systemic administration
by: Hong Shen, et al.
Published: (2016-09-01) -
Targeted Radiotherapeutics from 'Bench-to-Bedside'
by: Cristina Müller, et al.
Published: (2020-12-01) -
Tumor-targeting photodynamic therapy based on folate-modified polydopamine nanoparticles
by: Yan S, et al.
Published: (2019-08-01)